Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs yourEra

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and yourEra head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 17 · Grade B

yourEra

Visit yourEra Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 84 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make yourEra a bad call — it's best for people comparing a longer prepaid plan who can confirm the renewal price and refund terms before committing. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
84
Supply Reliability
95
83
Transparency
90
88
Access Breadth
93
86
Clinical Oversight
92
83
Track Record
88
80
CoreAge RxBrief Score 94 · 84yourEra

Price, coverage & the tracker

CoreAge RxyourEra
Brief Score94/100 (A)84/100 (B)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

From $79.20/mo equivalent on a prepaid 6-month plan ($475.20 total at the advertised new-patient discount); advertised month-to-month semaglutide $127.20 with the new-patient discount; confirm renewal at checkout

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

From $159.20/mo equivalent on a prepaid 6-month plan ($955.20 total at the advertised new-patient discount); renewal and monthly terms confirmed at checkout

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

yourEra: The $79.20 semaglutide and $159.20 tirzepatide monthly equivalents require six-month prepayment and a new-patient discount. Advertised month-to-month semaglutide is $127.20; confirm renewal pricing.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.